Federal Register / Vol. 60, No. 93 / Monday, May 15, 1995 / Notices 25919

A.1b—A list of all required assurances that

must be submitted with the plan;

A.1c—Copies of all certifications that are to

be complied with and clarification about

which one will have to be signed and

actually submitted with the plan.

Attachment A.2 presents the statutory basis

for five-year plan approval.

Attachment A.3 presents the statutory basis

for exempting eligible Indian Tribes from

inappropriate requirements.

★ Attachment B addresses the new CFS–

101, which consists of the State Annual

Budget Requests for title IV–B, subparts 1

and 2, and the State annual Summary of

Child Welfare Services. The new CFS–102 is

essentially an updated CWS–101 and

requests some new information so States can

receive their subpart 2 allotment:

Attachment B.1 provides a general

orientation to the new CFS–101. Included in

Attachment B.1 are:

B.1a—Information on the development of

the CFS–101;

B.1b–General directions and timeframes for

submission of the CFS–101.

Attachment B.2 provides instructions for

filling out the three forms which constitute

the CFS–101:

(Form 1) Part I: Annual Budget Request for

Title IV–B, Subpart 1, Child Welfare

Services. Part I is the same as the old CWS–

101 Part I: Annual Budget Request;

(Form 2) Part I Supplement: Annual

Budget Request for Title IV–B, Subpart 2.

Part I Supplement is a new form for States

to request funds from the Family

Preservation and Support Services Program;

(Form 3) Part II: Annual Summary of Child

and Family Services. Part II is essentially the

same as the old CWS–101 Part II, except that

some new information relevant to

implementation of the Family Preservation

and Support Services Program is being

requested

Copies of all the forms are enclosed.

Submittals: The Five-Year Plan

An original and two copies of the plan

must be submitted to the Administration for

Children and Families (ACF) Federal

Regional Office by June 30, 1995. Guidelines

can be found in Attachment A.

The CFS–101

The due dates for the Annual Budget

Requests and the Annual Summary of

Services for FYs 1995 and 1996 vary

depending upon a number of different

circumstances. Explicit instructions can be

found in Attachment B.

Submit the original (with original

signature) and two copies to the

Administration for Children and Families

(ACF) Federal Regional Office.

[FR Doc. 95–11825 Filed 5–12–95; 8:45 am]

BILLING CODE 4184–01–M

Agency Information Collection Under

OMB Review

Title: ACF—535 LIHEAP Quarterly

Estimates

OMB No.: 0970–0037

Description: The information collected

is used to develop our apportionment

request for appropriated Low-Income

Home Energy Assistance Programs

(LIHEAP) funds and to make grant

awards based on the funding needs of

States and Tribes.

Respondents: State and tribal

governments

Annual Number of Respondents: 55

sites

Number of responses per respondent: 1

Total annual responses: 55 sites

Hours per response: .25

Total Annual Burden Hours: 14

Additional Information: Copies of the

request for approval may be obtained

from Bob Sargis of the Office of

Information Resource Management,

ACF, by calling (202) 690–7275.

OMB Comment: Consideration will be

given to comments and suggestions

received within 30 days of

publication. Written comments and

recommendations for the proposed

information collection should be sent

directly to the following: Office of

Management and Budget, Paperwork

Reduction Project, 725 17th Street,

N.W., Washington, D.C. 20503, Attn:

Ms. Wendy Taylor.

Dated: May 8, 1995.

Roberta Katson,

Acting Director, Office of Information

Resource Management.

[FR Doc. 95–11826 Filed 5–12–95; 8:45 am]

BILLING CODE 4184–01–M

Food and Drug Administration

[Docket No. 95N–0109]

Animal Drug Export; Marbofloxacin

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Pfizer, Inc., has filed an application

requesting approval for the export of a

specific amount of the bulk form of the

new drug substance marbofloxacin to

France.

ADDRESSES: Relevant information on

this application may be directed to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

rm. 1–23, 12420 Parklawn Dr.,

Rockville, MD 20857, and to the contact

person identified below. Any future

inquiries concerning the export of

animal drugs under the Drug Export

Amendments Act of 1986 should also be

directed to the contact person.

FOR FURTHER INFORMATION CONTACT:

Gregory S. Gates, Center for Veterinary

Medicine (HFV–114), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1617.

SUPPLEMENTARY INFORMATION: The drug

export provisions in section 802 of the

Federal Food, Drug, and Cosmetic Act

(the act) (21 U.S.C. 382) provide that

FDA may approve applications for the

export of drugs that are not currently

approved in the United States. Section

802(b)(3)(B) of the act sets forth the

requirements that must be met in an

application for approval. Section

802(b)(3)(C) of the act requires that the

agency review the application within 30

days of its filing to determine whether

the requirements of section 802(b)(3)(B)

have been satisfied. Section 802

(b)(3)(A) of the act requires that the

agency publish a notice in the Federal

Register within 10 days of the filing of

an application for export to facilitate

public participation in its review of the

application. To meet this requirement,

the agency is providing notice that

Pfizer, Inc., 235 East 42d St., New York,

NY 10017, has filed application number

6936 requesting approval for the export

of a specific amount of the bulk form of

the new drug substance marbofloxacin

to France for further manufacture of the

finished dosage form Marbocyl, 5

milligram Tablets (antimicrobial for

treatment of dogs and cats). The tablets

will then be shipped to the United

Kingdom where they are approved for

marketing. The application was received

and filed in the Center for Veterinary

Medicine on April 24, 1995, which shall

be considered the filing date for

purposes of the act.

Interested persons may submit

relevant information on the application

to the Dockets Management Branch

(address above) in two copies (except

that individuals may submit single

copies) and identified with the docket

number found in brackets in the

heading of this document. These

submissions may be seen in the Dockets

Management Branch between 9 a.m. and

4 p.m., Monday through Friday.

The agency encourages any person

who submits relevant information on

the application to do so by May 25,

1995, and to provide an additional copy

of the submission directly to the contact

person identified above, to facilitate

consideration of the information during

the 30-day review period.

This notice is issued under the

Federal Food, Drug, and Cosmetic Act

(sec. 802 (21 U.S.C. 382)) and under

authority delegated to the Commissioner

of Food and Drugs (21 CFR 5.10) and

redelegated to the Center for Veterinary

Medicine D(21 CFR 5.44).